Discussion stirs around Humana Inc. (NYSE:HUM) this week; here is what analysts are saying.

August 9, 2018 - By Jack Shaw

Humana Inc. (NYSE:HUM) LogoInvestors sentiment decreased to 0.78 in 2018 Q1. Its down 0.27, from 1.05 in 2017Q4. It is negative, as 48 investors sold Humana Inc. shares while 233 reduced holdings. 53 funds opened positions while 165 raised stakes. 122.28 million shares or 2.59% less from 125.53 million shares in 2017Q4 were reported.
Renaissance Tech Limited Liability Company invested 0.96% of its portfolio in Humana Inc. (NYSE:HUM). Grantham Mayo Van Otterloo Ltd reported 171,615 shares. Sfmg Limited Liability Company accumulated 1,619 shares or 0.07% of the stock. Gotham Asset Mngmt Ltd Llc accumulated 0.07% or 18,104 shares. Country Tru Fincl Bank owns 0% invested in Humana Inc. (NYSE:HUM) for 25 shares. Scout Inc reported 0.36% in Humana Inc. (NYSE:HUM). Cleararc Capital Inc reported 3,529 shares. Factory Mutual reported 0.02% in Humana Inc. (NYSE:HUM). Legal & General Group Inc Public Limited Co, United Kingdom-based fund reported 742,646 shares. Da Davidson And holds 0.01% or 2,669 shares in its portfolio. Maverick Limited accumulated 45,140 shares or 0.16% of the stock. Td Asset Mngmt stated it has 149,420 shares or 0.06% of all its holdings. Moreover, Principal Fincl Grp Inc has 0.06% invested in Humana Inc. (NYSE:HUM). Spirit Of America Management Corp Ny holds 0.11% of its portfolio in Humana Inc. (NYSE:HUM) for 3,000 shares. South Dakota Investment Council invested in 0.54% or 87,545 shares.

Since February 24, 2018, it had 0 insider purchases, and 17 sales for $57.20 million activity. Fleming William Kevin also sold $4.58 million worth of Humana Inc. (NYSE:HUM) shares. BROUSSARD BRUCE D had sold 14,075 shares worth $3.86M. LeClaire Brian P. also sold $1.58M worth of Humana Inc. (NYSE:HUM) on Friday, June 15. Wheatley Timothy Alan also sold $3.43 million worth of Humana Inc. (NYSE:HUM) shares. On Saturday, February 24 BILNEY JODY L sold $801,477 worth of Humana Inc. (NYSE:HUM) or 2,931 shares. $4.45 million worth of Humana Inc. (NYSE:HUM) shares were sold by Huval Timothy S..

Humana Inc. (NYSE:HUM) Ratings Coverage

Among 9 analysts covering Humana (NYSE:HUM), 7 have Buy rating, 0 Sell and 2 Hold. Therefore 78% are positive. Humana has $375 highest and $25000 lowest target. $330.11’s average target is 1.82% above currents $324.22 stock price. Humana had 13 analyst reports since February 12, 2018 according to SRatingsIntel. Piper Jaffray maintained the stock with “Buy” rating in Tuesday, April 3 report. Citigroup maintained Humana Inc. (NYSE:HUM) rating on Friday, June 1. Citigroup has “Buy” rating and $340 target. The rating was maintained by BMO Capital Markets with “Outperform” on Monday, June 25. The rating was maintained by Morgan Stanley with “Overweight” on Thursday, July 12. The stock has “Hold” rating by Cantor Fitzgerald on Monday, April 23. On Thursday, August 2 the stock rating was maintained by Bank of America with “Buy”. The stock of Humana Inc. (NYSE:HUM) has “Buy” rating given on Monday, April 16 by Argus Research. The firm earned “Buy” rating on Thursday, August 2 by Jefferies. Cantor Fitzgerald maintained the stock with “Hold” rating in Wednesday, May 2 report. Morgan Stanley maintained the shares of HUM in report on Thursday, August 2 with “Overweight” rating. Below is a list of Humana Inc. (NYSE:HUM) latest ratings and price target changes.

02/08/2018 Broker: Jefferies Old Rating: Buy New Rating: Buy Old Target: $356 New Target: $372 Maintain
02/08/2018 Broker: Bank of America Old Rating: Buy New Rating: Buy Old Target: $338 New Target: $375 Maintain
02/08/2018 Broker: Morgan Stanley Old Rating: Overweight New Rating: Overweight Old Target: $362 New Target: $365 Maintain
12/07/2018 Broker: Morgan Stanley Rating: Overweight New Target: $362 Maintain
25/06/2018 Broker: BMO Capital Markets Old Rating: Outperform New Rating: Outperform Old Target: $328 New Target: $355 Maintain
01/06/2018 Broker: Citigroup Old Rating: Buy New Rating: Buy New Target: $340 Maintain
02/05/2018 Broker: Cantor Fitzgerald Rating: Hold New Target: $250.0000 Maintain
23/04/2018 Broker: Cantor Fitzgerald Rating: Hold New Target: $250.0000 Maintain
16/04/2018 Broker: Argus Research Old Rating: Buy New Rating: Buy Old Target: $270 New Target: $330 Maintain
12/04/2018 Broker: Jefferies Rating: Buy New Target: $356.0000 Maintain

The stock increased 0.76% or $2.43 during the last trading session, reaching $324.22. About 393,685 shares traded. Humana Inc. (NYSE:HUM) has risen 26.78% since August 9, 2017 and is uptrending. It has outperformed by 14.21% the S&P500.

Humana Inc., together with its subsidiaries, operates as a health and well-being firm in the United States. The company has market cap of $44.67 billion. The firm operates through three divisions: Retail, Group, and Healthcare Services. It has a 33.51 P/E ratio. The Retail segment offers Medicare benefits, as well as commercial fully-insured medical and specialty health insurance benefits, including dental, vision, and other supplemental health and financial protection products directly to individuals or through group accounts.

More news for Humana Inc. (NYSE:HUM) were recently published by: Seekingalpha.com, which released: “Humana (HUM) Q2 2018 Results – Earnings Call Transcript” on August 01, 2018. Fool.com‘s article titled: “Fitbit Makes Some Headway in Its Health Solutions Business” and published on August 07, 2018 is yet another important article.

Humana Inc. (NYSE:HUM) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.